1Department of Pharmacology, Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut (U.P.)
2Department of Pharmaceutical Chemistry, Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut (U.P.)
3Department of Pharmaceutics, NKBR College of Pharmacy, Meerut (U.P.)
4Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, Chelyabinsk, Russia
Online published on 24 April, 2025.
COVID-19 is the black chapter in the history of the world. Currently, many countries are facing different waves of this pandemic but the problem in front of us is the frequent mutants. Some questions are also coming about how we will treat future coming viruses.
Our aim in this research work is to perform the Molecular docking of important bioactive compounds of Gmelina arborea i.e. arboreol, gmelanone, gmelinol and hentriacontanol to the active site of 3CLpro.
The docking studies strongly suggest that Gmelina arborea can be used in the disease management. The need is to explore the plant Gmelina arborea, which can give directions in treatment in various diseases including COVID-19.
COVID-19 variants, Gmelina arborea, Quercetin, Apigenin, Luteolin, β-sitosterol
